Back to search

Sweden· SE-20170911000025

Alimemazin Evolan 40 mg/ml Orala droppar, lösning

A alimemazine product containing alimemazine, registered in Sweden by Evolan Pharma AB. The same ATC class is registered in 9 of our 19 countries.

ATC R06AD01

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAlimemazin Evolan 40 mg/ml Orala drop…ATCR06AD01REGISTER NO.SE-20170911000025PACKS LISTED1CHECKEDOctober 1, 2026

Where it is registered

Alimemazine is registered in 9 of 19 countries.

Countries holding a registration under ATC R06AD01 (alimemazine), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 5 of them publish a price we can compare per daily dose

Alimemazine · ATC R06AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Norwayprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alimemazine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Alimemazine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Alimemazine
Manufacturer
Evolan Pharma AB
Country
Sweden (SE)
ATC code
R06AD01
ATC class
Alimemazine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20170911000025

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

659 interactions on record for alimemazine.

Graded by severity as the source publishes them — 80 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alimemazine · interactions on record

659 records

  • 80 severe
  • 565 moderate
  • 14 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alimemazine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alimemazine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Spain · Variargil
  • France · Theralene
  • United Kingdom (Northern Ireland) · Alfresed, Alimemazine Tartrate
  • Iceland · Alimemazin Evolan
  • Malta · Alimemazine Thame
  • Norway · Alimemazin Evolan, Alimemazin Orifarm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abb67808-c59d-4c78-8d66-98f9d27877e4
GET /v1/drugs/abb67808-c59d-4c78-8d66-98f9d27877e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "PAR",
    "SmPC"
  ],
  "se_npl_id": "20170911000025",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20170911000025",
  "product_doc_link": "https://docetp.mpa.se/LMF/Alimemazin%20Evolan%20Orala%20drops%2C%20solution%20SmPC_09001bee807a2002.pdf"
}

See everything about alimemazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.